Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease

• André R. S. Périssé ,

  * E-mail: aperisse@ensp.fiocruz.br

  Affiliation Departamento de Ciências Biológicas, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

  ⨯
• Laura Smeaton,

  Affiliation Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Yun Chen,

  Affiliation Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Alberto La Rosa,

  Affiliation Asociacion Civil Impacta Salud y Educacion - Barranco, Lima, Peru

  ⨯
• Ann Walawander,

  Affiliation Frontier Science and Technology Research Foundation, Amherst, New York, United States of America

  ⨯
• Apsara Nair,

  Affiliation Frontier Science and Technology Research Foundation, Amherst, New York, United States of America

  ⨯
• Beatriz Grinsztejn,

  Affiliation Evandro Chagas Clinical Research Institute, Fiocruz, Rio de Janeiro, Brazil

  ⨯
• Breno Santos,

  Affiliation Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil

  ⨯
• Cecilia Kanyama,

  Affiliation Kamuzu Central Hospital, Lilongwe, Malawi

  ⨯
• James Hakim,

  Affiliation University of Zimbabwe College of Health Sciences, Harare, Zimbabwe

  ⨯
• Mulinda Nyirenda,

  Affiliation Mulinda Nyirenda, College of Medicine, University of Malawi, Blantyre, Malawi

  ⨯
• Nagalingeswaran Kumarasamy,

  Affiliation YRG Centre for AIDS Research and Education, Chennai, India

  ⨯
• Umesh G. Lalloo,

  Affiliation Nelson R. Mandela School of Medicine, Durban, South Africa

  ⨯
• Timothy Flanigan,

  Affiliation Brown Medical School, Providence, Rhode Island, United States of America

  ⨯
• Thomas B. Campbell,

  Affiliation Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America

  ⨯
•  [ ... ],
• Michael D. Hughes, P E A R L S study team of the ACTG

  Affiliation Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• [ view all ]
• [ view less ]